Parkwalk Advisors
Parkwalk Advisors is a London-based venture capital firm that focuses on UK technology companies with IP backing, primarily those spun out from UK universities. The firm invests across seed to growth stages, including late-stage rounds, and is stage-agnostic, aiming to support unlisted companies with freedom to operate. It concentrates on companies originating from university research, especially in Cambridge and across the UK, and targets sectors such as healthcare, energy, materials, technology, artificial intelligence, big data, life sciences, cleantech, medtech, quantum computing, and the apps ecosystem. Typical investments range from about £0.3 million to £10 million, with capital structures kept in a single share class, and the firm may provide equity or debt financings. Investments are generally planned over a three- to eight-year horizon.
Top Sectors
Top Regions
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
Past deals in Mechanical Engineering
Oxford Endovascular
Series A in 2024
Oxford Endovascular develops a neurovascular device to treat brain aneurysms. The device uses origami-inspired engineering with a laser-cut metal alloy that has shape-memory, enabling a catheter-delivered implant to expand into a tiny mesh tube that conforms to the vessel. By diverting blood flow away from the aneurysm, it promotes healing and reduces the risk of rupture.
Oxford Endovascular
Series B in 2021
Oxford Endovascular develops a neurovascular device to treat brain aneurysms. The device uses origami-inspired engineering with a laser-cut metal alloy that has shape-memory, enabling a catheter-delivered implant to expand into a tiny mesh tube that conforms to the vessel. By diverting blood flow away from the aneurysm, it promotes healing and reduces the risk of rupture.
Oxford Endovascular
Series A in 2021
Oxford Endovascular develops a neurovascular device to treat brain aneurysms. The device uses origami-inspired engineering with a laser-cut metal alloy that has shape-memory, enabling a catheter-delivered implant to expand into a tiny mesh tube that conforms to the vessel. By diverting blood flow away from the aneurysm, it promotes healing and reduces the risk of rupture.
Oxford Endovascular
Venture Round in 2018
Oxford Endovascular develops a neurovascular device to treat brain aneurysms. The device uses origami-inspired engineering with a laser-cut metal alloy that has shape-memory, enabling a catheter-delivered implant to expand into a tiny mesh tube that conforms to the vessel. By diverting blood flow away from the aneurysm, it promotes healing and reduces the risk of rupture.
Oxford Endovascular
Series A in 2015
Oxford Endovascular develops a neurovascular device to treat brain aneurysms. The device uses origami-inspired engineering with a laser-cut metal alloy that has shape-memory, enabling a catheter-delivered implant to expand into a tiny mesh tube that conforms to the vessel. By diverting blood flow away from the aneurysm, it promotes healing and reduces the risk of rupture.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.